Regulatory integrity is not optional—it's a clinical and legal imperative.

In the United States, any product classified as a drug—including homeopathic formulations—must carry a valid National Drug Code (NDC). This is not a formality; it is a federal requirement. An active NDC signifies that a product:

• Is formally recognised by the FDA as a drug product
• Meets applicable manufacturing and labelling standards
• Is traceable for clinical documentation, regulatory audits, and insurance oversight

Products lacking an active NDC are not FDA-compliant. Their distribution or use within a clinical setting places both patients and practitioners at risk. Such products may be detained at the border, seized, or subject to enforcement action. For prescribers, recommending or dispensing unregistered products may constitute a regulatory liability, particularly in institutional, licensure, or malpractice contexts.

Each Symbiopathic remedy is registered with an active NDC—ensuring lawful distribution, traceability, and clinical assurance across the United States.

Regulatory Alignment Without Exception

Symbiopathic remedies are fully registered under FDA requirements with active NDC labeler codes. We do not rely on exemptions, disclaimers, or ambiguous classification strategies. Every product is produced to pharmaceutical standards and documented for clinical transparency.

For practitioners working within terrain-based frameworks or European Biological Medicine, Symbiopathic offers continuity with the Enderlein tradition—delivered with structural integrity, legal clarity, and clinical reliability.